These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31770548)
61. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma. Hermann GG APMIS Suppl; 1993; 35():1-26. PubMed ID: 8251200 [No Abstract] [Full Text] [Related]
62. Modern concepts in the therapy of urinary tract (kidney, ureter, bladder and prostate) tumours. Lümmen G; Sperling H; Bex A; Otto T; Rübben H Pharmacol Res; 1998 Sep; 38(3):151-64. PubMed ID: 9782064 [No Abstract] [Full Text] [Related]
63. 6th Meeting of the European Society of Oncological Urology. Govorov A Expert Rev Anticancer Ther; 2009 Apr; 9(4):397-9. PubMed ID: 19374594 [TBL] [Abstract][Full Text] [Related]
64. [Arterial chemoembolization using microencapsulated anticancer drugs]. Sato K; Kato T Gan To Kagaku Ryoho; 1990 Jun; 17(6):1105-10. PubMed ID: 1693486 [TBL] [Abstract][Full Text] [Related]
65. [Immunotherapy in the treatment of genitourinary cancers]. Géczi L; Ladányi A; Vajdics T; Küronya Z; Bíró K; Gyergyay F; Martin T; Nagyiványi K Magy Onkol; 2016 Mar; 60(1):41-5. PubMed ID: 26934350 [TBL] [Abstract][Full Text] [Related]
66. [The trends and progress in the comprehensive treatments of urological malignance]. Li X; Li H Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):74-8. PubMed ID: 22455136 [TBL] [Abstract][Full Text] [Related]
67. Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature. Guler OC; Bal N; Onal C Clin Genitourin Cancer; 2016 Apr; 14(2):e211-3. PubMed ID: 26739102 [No Abstract] [Full Text] [Related]
68. [Combination radiotherapy-immunotherapy in genitourinary cancer]. Ollivier L; Guimas V; Rio E; Vaugier L; Masson I; Libois V; Labbé M; Fradin D; Potiron V; Supiot S Cancer Radiother; 2021 Oct; 25(6-7):565-569. PubMed ID: 34391648 [TBL] [Abstract][Full Text] [Related]
69. [Cooperation between specialists necessary in urologic oncology]. Bröte L Lakartidningen; 1988 Oct; 85(40):3274-5. PubMed ID: 3199955 [No Abstract] [Full Text] [Related]
70. Open clinical uro-oncology trials in Canada. Mackenzie MJ; Rodrigues G; Winquist E Can J Urol; 2009 Jun; 16(3):4706-11. PubMed ID: 19497189 [No Abstract] [Full Text] [Related]
71. Role of immunotherapy in the treatment of bladder and renal cell carcinoma. Stone NN; Droller MJ Semin Surg Oncol; 1991; 7(4):239-43. PubMed ID: 1925256 [TBL] [Abstract][Full Text] [Related]
72. Open clinical uro-oncology trials in Canada. Rodrigues G; Winquist E Can J Urol; 2010 Dec; 17(6):5494-9. PubMed ID: 21172119 [No Abstract] [Full Text] [Related]
74. [Recent advancement of the treatment of urological malignancies]. Akaza H Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():157-64. PubMed ID: 10410670 [TBL] [Abstract][Full Text] [Related]
75. Recent advances in immuno-oncology and its application to urological cancers. Mataraza JM; Gotwals P BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757 [TBL] [Abstract][Full Text] [Related]
77. Open clinical uro-oncology trials in Canada. Rodrigues G; Winquist E Can J Urol; 2011 Jun; 18(3):5751-6. PubMed ID: 21703055 [No Abstract] [Full Text] [Related]
78. Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002. Thompson E Drugs Today (Barc); 2002 Apr; 38(4):221-34. PubMed ID: 12532191 [No Abstract] [Full Text] [Related]
79. A solitary and synchronous metastasis of renal cell carcinoma to the bladder. Uygur MC; Ozen HA; Sungur A; Remzi D Int Urol Nephrol; 1994; 26(5):529-33. PubMed ID: 7860200 [TBL] [Abstract][Full Text] [Related]
80. Open clinical uro-oncology trials in Canada. Winquist E; Rodrigues G Can J Urol; 2011 Aug; 18(4):5849-55. PubMed ID: 21854720 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]